Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

BACKGROUND: Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders (PORs). Several studies showed that DHEA supplementation could improve IVF outcomes of PORs. However, most of the PORs do not respond to DHEA clinically. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Chern, Chyi-Uei, Tsui, Kuan-Hao, Vitale, Salvatore Giovanni, Chen, San-Nung, Wang, Peng-Hui, Cianci, Antonio, Tsai, Hsiao-Wen, Wen, Zhi-Hong, Lin, Li-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142344/
https://www.ncbi.nlm.nih.gov/pubmed/30223902
http://dx.doi.org/10.1186/s12958-018-0409-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142344/
https://www.ncbi.nlm.nih.gov/pubmed/30223902
http://dx.doi.org/10.1186/s12958-018-0409-z

Ejemplares similares